Recombinant Human RIPK1 Protein (Baculovirus)，His

Receptor-interacting protein kinase 1 (RIPK1) plays a crucial role in regulating cell death, inflammation, and survival pathways, making it a significant target for therapeutic intervention in various diseases, including cancer and neurodegenerative disorders. Initially identified as a mediator of tumor necrosis factor (TNF)-induced apoptosis and necroptosis, RIPK1 has garnered attention for its dual role in promoting cell death and facilitating cell survival depending on its interactions with other proteins and the cellular context. The understanding of RIPK1’s function has evolved, revealing its importance in signaling pathways such as NF-κB activation, which is essential for inflammatory responses. Moreover, aberrant RIPK1 activity has been implicated in pathologies where dysregulated apoptosis and inflammation contribute to disease progression. As a result, researchers have focused on producing recombinant RIPK1 proteins to study its structure, interactions, and functional regulation in detail. The development of these recombinant proteins has enabled advanced assays to elucidate the molecular mechanisms underlying RIPK1-mediated signaling and its implications in health and disease. By generating and characterizing RIPK1 recombinant proteins, scientists aim to identify potential modulators that could lead to novel therapeutic strategies targeting RIPK1 pathways, thereby offering insights into the prevention and treatment of diseases associated with dysregulated cell death and inflammation.